Falk Grace E, Rogers Jerad, Lu Liuqiang, Ablah Elizabeth, Okut Hayrettin, Vindhyal Mohinder R
Medical Students, 8586University of Kansas School of Medicine-Wichita, Wichita, KS, USA.
Department of Population Health, 8586University of Kansas School of Medicine-Wichita, Wichita, KS, USA.
J Intensive Care Med. 2022 Nov;37(11):1528-1534. doi: 10.1177/08850666221083644. Epub 2022 Mar 3.
Mortality estimates from sepsis and septic shock ranged from 18% to 35% and 40% to 60%, respectively, prior to 2014. Sepsis patients who experience subsequent cardiovascular events have increased mortality; however, data are limited among septic shock patients. This study reports in-hospital mortality, incident cardiovascular events, and cardiovascular procedures among sepsis patients with and without subsequent septic shock. Patients with a primary diagnosis of sepsis with and without a secondary diagnosis of septic shock were identified from the 2016 and 2017 National Readmissions Database. These patients were then evaluated for the occurrence of cardiovascular events and procedures. A total of 2,127,137 patients were included in the study, with a mean age of 66 years. Twenty percent of patients (n = 420,135) developed subsequent septic shock. In-hospital mortality among patients with a primary diagnosis of sepsis was 5.3%, and it was 31.2% for those with subsequent septic shock. Notable cardiovascular events occurring among sepsis patients with and without subsequent septic shock, respectively, included: acute kidney injury (65.1% vs. 32.8%, < .0001), acute systolic heart failure (9.8% vs. 5.1%, < .0001), NSTEMI (8.8% vs. 3.2%, < .0001), and ischemic stroke (2.3% vs. 0.9%, < .0001). Similarly, the most common cardiovascular procedures between the two groups were: percutaneous coronary intervention (0.37% vs. 0.20%, < .0001), intra-aortic balloon pump (0.19% vs. 0.02%, < .0001), and extracorporeal membrane oxygenation (0.18% vs. 0.01%, < .0001). Sepsis with subsequent septic shock is associated with an increased frequency of in-hospital cardiovascular events and procedures.
在2014年之前,脓毒症和脓毒性休克的死亡率估计分别为18%至35%和40%至60%。经历后续心血管事件的脓毒症患者死亡率会升高;然而,脓毒性休克患者的数据有限。本研究报告了伴有或不伴有后续脓毒性休克的脓毒症患者的院内死亡率、心血管事件发生率以及心血管手术情况。从2016年和2017年全国再入院数据库中识别出原发性诊断为脓毒症且伴有或不伴有继发性脓毒性休克诊断的患者。然后对这些患者的心血管事件和手术情况进行评估。共有2127137名患者纳入研究,平均年龄为66岁。20%的患者(n = 420135)发生了后续脓毒性休克。原发性诊断为脓毒症的患者院内死亡率为5.3%,而发生后续脓毒性休克的患者为31.2%。伴有或不伴有后续脓毒性休克的脓毒症患者中发生的显著心血管事件分别包括:急性肾损伤(65.1%对32.8%,P <.0001)、急性收缩性心力衰竭(9.8%对5.1%,P <.0001)、非ST段抬高型心肌梗死(8.8%对3.2%,P <.0001)以及缺血性卒中(2.3%对0.9%,P <.0001)。同样,两组中最常见的心血管手术分别为:经皮冠状动脉介入治疗(0.37%对0.20%,P <.0001)、主动脉内球囊反搏(0.19%对0.02%,P <.0001)以及体外膜肺氧合(0.18%对0.01%,P <.0001)。伴有后续脓毒性休克的脓毒症与院内心血管事件和手术的发生率增加相关。